期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 424, 期 3, 页码 211-219出版社
ELSEVIER
DOI: 10.1016/S0014-2999(01)01153-0
关键词
anandamide; cannabinoid; capsaicin; mesenteric arterial bed; sensory nerve; vanilloid receptor
The effects of three structurally related cannabinoids on human and rat recombinant vanilloid VR1 receptors expressed in human embryonic kidney (HEK293) cells and at endogenous vanilloid receptors in the rat isolated mesenteric arterial bed were studied. In the recombinant cells, all three were full agonists, causing concentration-dependent increases in [Ca2+](i) (FLIPR(TM)), with a rank order of potency relative to the vanilloids capsaicin and olvanii, of olvanil greater than or equal to capsaicin > AM404 ((allZ)-N-(4-hydroxyphenyl)-5,8,11,14-eicosatetraenamide) > anandamide > methanandamide. These responses were inhibited by the vanilloid VR1 receptor antagonist, capsazepine. In the mesenteric arterial bed, vasorelaxation was evoked by these ligands with a similar order of potency. The AM404-induced vasorelaxation was virtually abolished by capsaicin pretreatment. AM404 inhibition of capsaicin-sensitive sensory neurotransmission was blocked by ruthenium red, but not by cannabinoid CB1 and CB2 receptor antagonists. AM404 had no effect on relaxations to calcitonin gene-related peptide. These data demonstrate that the vasorelaxant and sensory neuromodulator properties of AM404 in the rat isolated mesenteric arterial bed are mediated by vanilloid VR1 receptors. (C) 2001 Elsevier Science B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据